AI & Informatics: Drug discovery and development – industry survey infographic
View Drug Target Review's new infographic on the use of AI and informatics within early therapeutic development here.
List view / Grid view
View Drug Target Review's new infographic on the use of AI and informatics within early therapeutic development here.
Nanoengineers have developed a high-throughput bioprinter that 3D prints at record speed, potentially accelerating drug development.
Researchers have developed software that can design complex DNA nanodevices which could be used to deliver medicine while in the body.
A flow mode Raman-activated cell sorter called FlowRACS has been created by researchers for high-throughput discovery of enzymes and their cell factories.
The autonomous robot scientist can independently perform experimental procedures and makes its own decisions about which tests to perform.
The future of drug discovery lies in an automated world where the workflows for biological assays, chemical synthesis and data analysis are connected by flexible, mobile and modular hardware, integrated with software solutions that will interface with scientists for increased efficiency and productivity (the realisation of Industry 4.0). This article…
In this in-depth focus are features on the best data management options currently available and how the future of drug discovery will be connected and fully automated.
Researchers have used virtual reality (VR) to control how drugs bind to their protein targets, which they say could be useful for designing new treatments.
A new microfluidic technology has been developed by researchers, which utilises magnetic ferrobots to automate chemical analyses and assays.
A new platform combines AI, flow chemistry and robotics to minimise the need for human intervention in the synthesis process.
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumour or another disease site.
For drug discovery and biomarker research, screening campaigns are employed to identify potential new treatments for diseases and to answer questions that remain unknown in the scientific community.
Advances in genomics and structural biology are providing drug discovery scientists with more biological targets to prosecute, and greater information about each one.
A new scorpion-milking robot designed to extract venom could replace the traditional manual method.
Radisens Diagnostics, an Irish medtech business, is aiming to raise £22 million to bring its innovative diabetes management platform to market...